Immigration in a Changing World
In the hotly contested debate surrounding U.S. immigration policy, what does it take to find common ground? Alexander Kustov, an expert in public opinion and democratic governance and a professor of global affairs at the University of Notre Dame, joins host Sandro Galea to discuss the factors driving this debate.
Alexander Kustov
WashU launches doctoral program in neuroengineering
WashU will launch a doctoral program in neuroengineering in fall 2027, one of only a few in the United States.
Baer installed as Knight Family Professor
Markus Baer, vice dean of executive education at Olin Business School, has been installed as the Knight Family Professor of Organizational Behavior.
Guaranteed income improved artists’ finances, innovation
A guaranteed income program for artists led to improvement in financial stability and reduced debt, but also improved their motivation and artistic output, finds a new study from the WashU Brown School.
Research highlights who wins, loses in AI-influenced job market
A survey conducted by WashU graduate students shows workers are using artificial intelligence not just to do tasks faster, but to help them learn new skills, plan career moves or transition into new fields.
Mackey to deliver annual Brauer Lecture
John Mackey, co-founder of Whole Foods Market, will deliver the keynote address April 14 for WashU Olin Business School’s annual Brauer Lecture Series.
Mortimer installed as James Langenfeld Professor of Industrial Organization
Julie Holland Mortimer is a renowned applied microeconomics scholar in WashU Arts & Sciences. She investigates the impact of new forms of contracting between content producers and internet retailers.
Mazzeo installed as Judy and Jerry Kent Dean
Mike Mazzeo, the Knight Family Professor of Economics and dean of WashU Olin Business School, was installed Feb. 3 as the inaugural Judy and Jerry Kent Dean.
WashU among top 100 US universities granted utility patents
The National Academy of Inventors has once again named WashU to its Top 100 U.S. Universities Granted Utility Patents List.
Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
Developed by WashU Medicine researchers and licensed to WashU startup Wugen, the immunotherapy is designed to treat rare and aggressive types of blood cancer.
Older Stories